Scienture Holdings Enters Material Definitive Agreement

Ticker: SCNX · Form: 8-K · Filed: Oct 24, 2025 · CIK: 1382574

Scienture Holdings, Inc. 8-K Filing Summary
FieldDetail
CompanyScienture Holdings, Inc. (SCNX)
Form Type8-K
Filed DateOct 24, 2025
Risk Levelmedium
Pages3
Reading Time4 min
Key Dollar Amounts$0.00001, $325,000, $400,000, $175,000
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, company-name-change

TL;DR

Scienture Holdings just signed a big deal, filing an 8-K today.

AI Summary

On October 20, 2025, Scienture Holdings, Inc. entered into a material definitive agreement. The filing also includes financial statements and exhibits related to this agreement. The company was formerly known as TRxADE HEALTH, INC. and TRXADE GROUP, INC.

Why It Matters

This filing indicates a significant new contract or partnership for Scienture Holdings, Inc., which could impact its future financial performance and strategic direction.

Risk Assessment

Risk Level: medium — Entering into a material definitive agreement can introduce new risks and opportunities, the specifics of which are not detailed in this initial filing.

Key Players & Entities

  • Scienture Holdings, Inc. (company) — Registrant
  • TRxADE HEALTH, INC. (company) — Former company name
  • TRXADE GROUP, INC. (company) — Former company name
  • October 20, 2025 (date) — Date of earliest event reported

FAQ

What is the nature of the material definitive agreement entered into by Scienture Holdings, Inc. on October 20, 2025?

The filing does not specify the details of the material definitive agreement, only that one was entered into on October 20, 2025.

What are the financial statements and exhibits included with this 8-K filing?

The filing indicates that financial statements and exhibits are included, but their specific content is not detailed in the provided text.

When was Scienture Holdings, Inc. previously known as TRxADE HEALTH, INC.?

The company changed its name from TRxADE HEALTH, INC. on June 2, 2021.

What is the principal executive office address for Scienture Holdings, Inc.?

The principal executive offices are located at 20 Austin Blvd., Commack, NY 11725.

What is the SIC code for Scienture Holdings, Inc.?

The Standard Industrial Classification code for Scienture Holdings, Inc. is 2834, Pharmaceutical Preparations.

Filing Stats: 1,044 words · 4 min read · ~3 pages · Grade level 10.9 · Accepted 2025-10-24 17:05:58

Key Financial Figures

  • $0.00001 — ch registered Common stock, par value $0.00001 per share SCNX The Nasdaq Stock Mar
  • $325,000 — ani's annual base salary increased from $325,000 to $400,000 and Dr. Hariharan's annual
  • $400,000 — base salary increased from $325,000 to $400,000 and Dr. Hariharan's annual base salary
  • $175,000 — ran's annual base salary increased from $175,000 to $400,000, each subject to periodic r

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCIENTURE HOLDINGS, INC. By: /s/ Dr. Narasimhan Mani Dr. Narasimhan Mani Co-Chief Executive Officer Date: October 24, 2025

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.